MADRIGAL PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $3.11M, a 78.75% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.33M, a 73.04% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $17.73M.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.74M, a 97.97% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2025 was $38.05M.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2017 was $173.81M, a 2819.13% increase from fiscal 2016.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2016 was $5.95M.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2011 was $27.10M, a 16.75% increase from fiscal 2010.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $3.11M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $2.33M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $38.05M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $17.73M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.74M 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $8.64M 10-Q · filed 2026-07-30 | |
| 2024-06-30 | $85.95M 10-Q · filed 2024-10-31 | |
| 2024-03-31 | $311.56M 10-Q · filed 2024-10-31 | |
| 2023-09-30 | $2.73M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $21.75M 10-Q · filed 2024-10-31 | |
| 2017-12-31 | $173.81M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $5.95M 10-K · filed 2018-03-13 | |
| 2011-12-31 | $27.10M 10-K · filed 2012-02-22 | |
| 2010-12-31 | $23.21M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |